I am a physician-scientist and hepatologist at the University of Southern California with a research interest in Drug-Induced Liver Injury and Autoimmune Liver Diseases. I study mechanisms of liver injury and hepatotoxicity with a particular focus on cell death pathways using basic, animal model, and translational approaches. My lab currently focuses on Immune-mediated Liver Injury from Checkpoint Inhibitors and the complex interplay if signaling mechanisms leading to hepatotoxicity in immunotherapy.

I studied Medicine at the Catholic University of Louvain in Belgium. A fter graduating in 1982, I completed an Internal Medicine Residency in New York City. Thereafter, I entered the Gastroenterology and Hepatology Fellowship at the University of Southern California (USC), graduating in 1989. My professional career started at the University of Missouri-Kansas City, followed by a return at USC from 1992-2001 and a Liver Transplant position at California Pacific Medical Center from 2002-2012.

Allison Kwong is a hepatologist who specializes in the care of patients with chronic liver disease. Her research in alcohol-associated liver disease has been supported by the AASLD Foundation Clinical, Translational, and Outcomes Research Award and a NIAAA K23 Mentored Career Development Award. Her clinical and research interests include cirrhosis, portal hypertension, and outcomes before and after liver transplantation.

PGY3 at UMass

Vlad Fomin, MD is currently a liver transplant fellow at Columbia University/Weill Cornell Medicine. He received his MD from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and completed his internal medicine residency at Massachusetts General Hospital, followed by gastroenterology fellowship at Weill Cornell Medicine. Dr. Fomin's clinical and research interests focus on alcohol-associated liver disease and implementing multidisciplinary care models to optimize outcomes for this patient population.

Professor Young-Suk Lim currently serves as the Dean of the University of Ulsan College of Medicine and is a Professor in the Department of Gastroenterology, Asan Medical Center, South Korea. Prof. Lim is the President Elect of the Korean Association for the Study of the Liver (KASL) for the term spanning December 2025 to November 2027.
He served as the Director of the Clinical Trial Center at Asan Medical Center from April 2015 to June 2019.

Dr. Dhanasekaran is a physician scientist specializing in liver cancer research and patient care. Dr. Dhanasekaran completed her medical school training in India, and pursued her Internal Medicine residency at the University of Florida, Gainesville followed by Gastroenterology fellowship at Mayo Clinic, Rochester and Transplant Hepatology fellowship and PhD in Cancer Biology at Stanford University. Her clinical practice is mainly focused on liver cancer and she runs a clinic specifically for patients with liver masses. At Stanford, Dr.